docdok.health

docdok.health Overview

docdok.health is a GDPR- and HIPAA-compliant healthcare communication platform designed to strengthen the traditional patientdoctor relationship. The platform integrates with doctors' primary software and patients' medical devices. The company's complementary research and study module connects the clinical and research ecosystems. Based on these functionalities, docdok facilitates the gathering of quality assessments, the running of clinical trials, and the design and delivery of digital therapeutics. The universal docdok platform digitalizes the traditional physicianpatient interface in order to address major pain points and enrich existing clinical information from hospitals, private doctors, and day-to-day patient-generated health data, both in clinical and research settings. In this way, docdok seeks to shift healthcare to a value-based model, in which real-world evidence becomes mandatory. docdok's mission is to enable value-based healthcare as a global leader in capturing, understanding, and enhancing real-world patient outcomes at lower costs in the clinical and study ecosystem. docdok.health operates a 100% innovation and tech/IT development daughter company in Israel.

Cumulative Funding Raised Over Time ($)

Latest News

Feb 16, 2021 · www.prdistribution.com

growth-positive

docdok.health Announces Partnership With Leading German Medical Association

Swiss/Israeli digital health start-up docdok.health has entered into an exclusive partnership with the German umbrella organization of specialized physicians (SpiFa) and its subsidiary, the German Institute for Specialist Health Services Research (DIFA). The partnership aims to develop and distribute the DIFA1 app, a GDPR-compliant app that allows healthcare professionals to document the effectiveness and safety of their COVID-19 vaccinations. The data collected will be used for a study conducted by DIFA to evaluate the vaccination. The partnership is seen as a valuable contribution to the fight against the coronavirus and aims to generate more transparency regarding the effectiveness and safety of COVID-19 vaccines. The DIFA1 app is based on the DiGA1 app developed by docdok.health and will be available as a reimbursable medical product in the German healthcare system in Q2 2021.

PartnersCustomers

Oct 13, 2020 · www.startupticker.ch

growth-positive

docdok.health closes an oversubscribed financing round

Swiss-Israeli digital health start-up docdok.health AG has closed an oversubscribed funding round, indicating significant interest in its post-seed financing. The company offers a cloud-based platform called docdok for communication between healthcare providers and patients. It has found success with top hospitals, pharmaceutical companies, medical associations, and tech firms as customers and partners. The COVID-19 pandemic has increased the demand for digital health solutions, leading to rapid growth for docdok.health. The funding will be used to accelerate the international roll-out of the platform, hire key personnel, and develop new digital health applications and therapeutics.

CustomersInvestment

Apr 9, 2019 · www.healthcareitnews.com

growth-positive

Health Hub Vienna accepts Swiss startup docdok.health

Swiss startup docdok.health has been selected to be part of the innovation network of the Health Hub Vienna. This opportunity allows the company to network with stakeholders in the Austrian healthcare sector and potentially collaborate on joint projects. docdok.health has already demonstrated the benefits of its doctor-patient platform in Switzerland and Germany and has received awards for its work. The startup has developed digital therapy solutions for asthma and COPD and is currently implementing a COPD project with Novartis in Germany. The inclusion in the Health Hub Vienna provides docdok.health with the chance to expand its presence in the Austrian health market and engage in discussions on establishing technical innovation in the sector.

PartnersExpand

Oct 12, 2017 · www.verdict.co.uk

growth-positive

IBM and health startup docdok.health are using big data and apps to tackle lung disease

IBM Research is collaborating with health startup docdok.health to develop technologies to help patients and doctors manage chronic obstructive pulmonary disease (COPD). The project, named CAir, will begin clinical trials in Zurich next year. Participants in the trial will wear Internet of Things (IoT) devices to record symptoms, which will be accessed by doctors using docdok.healths platform. The data collected will be analyzed using IBMs artificial intelligence (AI) software to detect patterns and correlations. The goal is to improve patient care and prevent exacerbations of the disease. The collaboration aims to make healthcare more data-driven and patient-centric, allowing doctors to focus more on patient interaction. The technology is still in its early stages but shows promise for the future of healthcare.

CustomersPartners

Funding

Team Members

4

Employees: 1-10

Web & Social Links

Locations

Derech Sheba 2, Ramat Gan, Israel

Florastrasse 44, Basel, Switzerland

Photos & Videos

1 item(s)

docdok.health Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info